Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Terumo Aortic Global Endovascular Registry

Key facts

Where
Ann Arbor, Aurora, Austin, Camden, Charlottesville, Chicago, Colorado Springs, Gainesville, Indianapolis, Long Beach, New Haven, Norfolk, Philadelphia, Pittsburgh, Salt Lake City, Texas City, and Washington D.C., United StatesSee the 17 sites

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Shinichi Fukuhara, MD (principal investigator)Taking people
  • University of Colorado Anschutz Medical CampusAurora, United StatesContact: Rafael Malgor, MD (principal investigator)Taking people
  • Ascension Texas Cardiovascular / UT Dell Medical SchoolAustin, United StatesContact: Joshua Grimm (principal investigator)Taking people
  • Cooper University HospitalCamden, United StatesContact: Joseph Lombardi (principal investigator)Taking people
  • University of VirginaCharlottesville, United StatesContact: Bezhad Farivar (principal investigator)Taking people
  • Loyola University of Chicago (Loyola)Chicago, United StatesContact: Carlos Bechara, MD (principal investigator)Taking people
  • UC Health Memorial Hospital CenterColorado Springs, United StatesContact: Melham Sharafuddin (principal investigator)Taking people
  • University of FloridaGainesville, United StatesContact: Eric Jeng (principal investigator)Taking people
  • Ascension St. Vincent Heart CenterIndianapolis, United StatesContact: Sina L Moainie, MD (principal investigator)Taking people
  • Long Beach Memorial Medical CenterLong Beach, United StatesContact: Ali Khoynezhad (principal investigator)Taking people
  • Yale UniversityNew Haven, United StatesContact: Prashanth Vallabhajoysyula (principal investigator)Taking people
  • Sentara Heart HospitalNorfolk, United StatesContact: Jean Panneton, MD (principal investigator)Taking people
  • University of PennsylvaniaPhiladelphia, United StatesContact: Wilson Szeto (principal investigator)Taking people
  • University of PittsburghPittsburgh, United StatesContact: Ibrahim Sulton (principal investigator)Taking people
  • University of UtahSalt Lake City, United StatesContact: Jason Glozbach (principal investigator)Taking people
  • Baylor, Scott & White Health (BSW Health)Texas City, United StatesContact: Dennis Gable, MD (principal investigator)Taking people
  • MedStar Washington Hospital CenterWashington D.C., United StatesContact: Christian Shults (principal investigator)Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Vascutek Ltd.
Trial code
NCT04246463
Record updated
13 March 2026
Original description
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.Read full original descriptionShow less

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

Inclusion: Minimum age as per local regulations; Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft; Ability to provide informed consent; o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR); Willingness to comply with the registry protocol; Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up.

Exclusion: Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure.

ClinicalTrials.gov NCT04246463